AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
+2.37%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$56.8M
AUM Growth
+$56.8M
(-8.9%)
Cap. Flow
-$5.47M
Cap. Flow
% of AUM
-9.64%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
$5.47M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Annexon
ANNX
$226M
| $38M | 66.89% |
7,406,024
| – | – |
|
2
Akebia Therapeutics
AKBA
$833M
| $10.9M | 19.23% |
5,747,906
| – | – |
|
|
VRNA
3
Verona Pharma
VRNA
$9.16B
| $4.09M | 7.19% |
88,000
-117,880
| -57% | -$5.47M |
|
4
American Well
AMWL
$111M
| $3.8M | 6.69% |
523,785
| – | – |
|
|
WHWK
5
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $2.08K | ﹤0.01% |
659
| – | – |
|